BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 26872090)

  • 1. Comparative Assessment of Female Mouse Model of Graves' Orbitopathy Under Different Environments, Accompanied by Proinflammatory Cytokine and T-Cell Responses to Thyrotropin Hormone Receptor Antigen.
    Berchner-Pfannschmidt U; Moshkelgosha S; Diaz-Cano S; Edelmann B; Görtz GE; Horstmann M; Noble A; Hansen W; Eckstein A; Banga JP
    Endocrinology; 2016 Apr; 157(4):1673-82. PubMed ID: 26872090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutting edge: retrobulbar inflammation, adipogenesis, and acute orbital congestion in a preclinical female mouse model of Graves' orbitopathy induced by thyrotropin receptor plasmid-in vivo electroporation.
    Moshkelgosha S; So PW; Deasy N; Diaz-Cano S; Banga JP
    Endocrinology; 2013 Sep; 154(9):3008-15. PubMed ID: 23900776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic immunization with mouse thyrotrophin hormone receptor plasmid breaks self-tolerance for a murine model of autoimmune thyroid disease and Graves' orbitopathy.
    Schlüter A; Horstmann M; Diaz-Cano S; Plöhn S; Stähr K; Mattheis S; Oeverhaus M; Lang S; Flögel U; Berchner-Pfannschmidt U; Eckstein A; Banga JP
    Clin Exp Immunol; 2018 Mar; 191(3):255-267. PubMed ID: 29058307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Early Wave of Macrophage Infiltration Intertwined with Antigen-Specific Proinflammatory T Cells and Browning of Adipose Tissue Characterizes the Onset of Orbital Inflammation in a Mouse Model of Graves' Orbitopathy.
    Philipp S; Horstmann M; Hose M; Daser A; Görtz GE; Jesenek C; Flögel U; Hansen W; Bechrakis N; Banga JPS; Eckstein A; Berchner-Pfannschmidt U
    Thyroid; 2022 Mar; 32(3):283-293. PubMed ID: 34779257
    [No Abstract]   [Full Text] [Related]  

  • 5. Gut microbiota in experimental murine model of Graves' orbitopathy established in different environments may modulate clinical presentation of disease.
    Masetti G; Moshkelgosha S; Köhling HL; Covelli D; Banga JP; Berchner-Pfannschmidt U; Horstmann M; Diaz-Cano S; Goertz GE; Plummer S; Eckstein A; Ludgate M; Biscarini F; Marchesi JR;
    Microbiome; 2018 May; 6(1):97. PubMed ID: 29801507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic Phenotype of Adipogenesis and Hyaluronan in Orbital Fibroblasts From Female Graves' Orbitopathy Mouse Model.
    Görtz GE; Moshkelgosha S; Jesenek C; Edelmann B; Horstmann M; Banga JP; Eckstein A; Berchner-Pfannschmidt U
    Endocrinology; 2016 Oct; 157(10):3771-3778. PubMed ID: 27552248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Promising Mouse Model of Graves' Orbitopathy Induced by Adenovirus Expressing Thyrotropin Receptor A Subunit.
    Zhang M; Ding X; Wu LP; He MQ; Chen ZY; Shi BY; Wang Y
    Thyroid; 2021 Apr; 31(4):638-648. PubMed ID: 33076782
    [No Abstract]   [Full Text] [Related]  

  • 8. Orbital fibrosis in a mouse model of Graves' disease induced by genetic immunization of thyrotropin receptor cDNA.
    Zhao SX; Tsui S; Cheung A; Douglas RS; Smith TJ; Banga JP
    J Endocrinol; 2011 Sep; 210(3):369-77. PubMed ID: 21715431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling Graves' Orbitopathy in Experimental Graves' Disease.
    Banga JP; Moshkelgosha S; Berchner-Pfannschmidt U; Eckstein A
    Horm Metab Res; 2015 Sep; 47(10):797-803. PubMed ID: 26287396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy.
    Dik WA; Virakul S; van Steensel L
    Exp Eye Res; 2016 Jan; 142():83-91. PubMed ID: 26675405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyrotropin Receptor-Specific Lymphocytes in Adenovirus-TSHR-Immunized Native and Human Leukocyte Antigen-DR3-Transgenic Mice and in Graves' Disease Patient Blood.
    Degen H; Gavvovidis I; Blankenstein T; Uhland K; Ungerer M
    Thyroid; 2021 Jun; 31(6):950-963. PubMed ID: 33208049
    [No Abstract]   [Full Text] [Related]  

  • 12. TSH receptor-adenovirus-induced Graves' hyperthyroidism is attenuated in both interferon-gamma and interleukin-4 knockout mice; implications for the Th1/Th2 paradigm.
    Nagayama Y; Saitoh O; McLachlan SM; Rapoport B; Kano H; Kumazawa Y
    Clin Exp Immunol; 2004 Dec; 138(3):417-22. PubMed ID: 15544617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fingolimod Improves the Outcome of Experimental Graves' Disease and Associated Orbitopathy by Modulating the Autoimmune Response to the Thyroid-Stimulating Hormone Receptor.
    Plöhn S; Hose M; Schlüter A; Michel L; Diaz-Cano S; Hendgen-Cotta UB; Banga JP; Bechrakis NE; Hansen W; Eckstein A; Berchner-Pfannschmidt U
    Thyroid; 2019 Sep; 29(9):1286-1301. PubMed ID: 31237525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reevaluating thyrotropin receptor-induced mouse models of graves' disease and ophthalmopathy.
    Baker G; Mazziotti G; von Ruhland C; Ludgate M
    Endocrinology; 2005 Feb; 146(2):835-44. PubMed ID: 15542454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDGF enhances orbital fibroblast responses to TSHR stimulating autoantibodies in Graves' ophthalmopathy patients.
    van Steensel L; Hooijkaas H; Paridaens D; van den Bosch WA; Kuijpers RW; Drexhage HA; van Hagen PM; Dik WA
    J Clin Endocrinol Metab; 2012 Jun; 97(6):E944-53. PubMed ID: 22438231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients.
    van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A
    Thyroid; 2010 May; 20(5):535-44. PubMed ID: 20384487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulating gut microbiota in a mouse model of Graves' orbitopathy and its impact on induced disease.
    Moshkelgosha S; Verhasselt HL; Masetti G; Covelli D; Biscarini F; Horstmann M; Daser A; Westendorf AM; Jesenek C; Philipp S; Diaz-Cano S; Banga JP; Michael D; Plummer S; Marchesi JR; Eckstein A; Ludgate M; Berchner-Pfannschmidt U;
    Microbiome; 2021 Feb; 9(1):45. PubMed ID: 33593429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmunity in Graves' ophthalmopathy: the result of an unfortunate marriage between TSH receptors and IGF-1 receptors?
    Wiersinga WM
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2386-94. PubMed ID: 21677036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current insights into the pathogenesis of Graves' orbitopathy.
    Eckstein AK; Johnson KT; Thanos M; Esser J; Ludgate M
    Horm Metab Res; 2009 Jun; 41(6):456-64. PubMed ID: 19530272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide scanning for thyrotropin receptor T-cell epitopes in mice vaccinated with naked DNA.
    Pichurin P; Schwarz-Lauer L; Braley-Mullen H; Paras C; Pichurina O; Morris JC; Rapoport B; McLachlan SM
    Thyroid; 2002 Sep; 12(9):755-64. PubMed ID: 12481940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.